Skip to main content

James Hoffman, Pharm.D., named American Society of Health-System Pharmacists fellow

Memphis, Tennessee, May 29, 2013

James Hoffman, PharmD

James Hoffman, Pharm.D., has been recognized by the American Society of Health-System Pharmacists for excellence in pharmacy practice.

James M. Hoffman, Pharm.D., medication outcomes and safety officer at St. Jude Children’s Research Hospital, has been named a fellow by the American Society of Health-System Pharmacists (ASHP) for excellence in pharmacy practice.

Hoffman, an associate member in the St. Jude Pharmaceutical Sciences Department, is an expert in national drug shortages and also focuses on medication safety, patient safety event detection and reporting systems, clinical decision support in the electronic health record, and clinical applications of pharmacogenomics.

Hoffman was an invited presenter at the Food and Drug Administration Center for Drug Evaluation and Research Public Workshop on Drug Shortages in September 2011. He also led a national survey of oncology pharmacists published in March 2013 that found drug shortages are taking a heavy toll on cancer patients, leading to higher costs as well as treatment changes and delays.

Hoffman has published research in journals including Cancer, Journal of Pediatrics and New England Journal of Medicine. He has also authored various book chapters, reviews and abstracts. Hoffman received his bachelor’s and Doctor of Pharmacy degrees at the University of the Sciences in Philadelphia and a Masters of Science from the University of Wisconsin-Madison.

The 2013 fellows will be honored in June during the ASHP Summer Meeting and Exhibition in Minneapolis.

ASHP is a national professional organization whose 40,000 members include pharmacists, pharmacy technicians and pharmacy students who provide patient care services in hospitals, health systems and ambulatory clinics.

St. Jude Children's Research Hospital

St. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer and other life-threatening diseases. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20% to 80% since the hospital opened more than 50 years ago. St. Jude shares the discoveries it makes, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children. To learn more, visit or follow St. Jude on social media at @stjuderesearch.